Reversible dilated cardiomyopathy associated with amphotericin B treatment

Moyssakis, Ioannis; Vassilakopoulos, Theodoros P.; Sipsas, Nikolaos V.; Perakis, Alexandros; Petrou, Alexandra; Kosmas, Nikolaos; Pangalis, Gerassimos A.

doi:10.1016/j.ijantimicag.2005.02.015

Cited by 16 publications

(18 citation statements)

References 12 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…AmB‐induced cardiomyopathy is a reversible condition. In our patient, as with all the previously reported cases, the cardiac function returned to normal.…”

Section: Details Of the Casesupporting

confidence: 90%

“…Unlike the previously reported cases, our patient had no predisposing factor for heart failure. According to some authors, the presence of predisposing factors to cardiac dysfunction is the most important factor for the development of AmB‐related cardiomyopathy .…”

Section: Details Of the Casecontrasting

confidence: 71%

“…Although widely used, AmB is commonly associated with numerous adverse effects, especially kidney dysfunction. Reversible dilated cardiomyopathy attributed to AmB is a rare event, with very few reported cases, and all of these involved patients who presented with a predisposing factor for heart failure …”

Section: What Is Known and Objectivementioning

confidence: 99%

“…AmB is also known to cause myopathy mediated by hypokalaemia. Despite these known cardiac toxicities, only four cases of reversible dilated cardiomyopathy caused by this agent have been reported …”

Section: Details Of the Casementioning

confidence: 99%

See 3 more Smart Citations

Reversible dilated cardiomyopathy associated with amphotericin B therapy

et al. 2014

View full text Add to dashboard Cite

show abstract

“…AmB‐induced cardiomyopathy is a reversible condition. In our patient, as with all the previously reported cases, the cardiac function returned to normal.…”

Section: Details Of the Casesupporting

confidence: 90%

Section: Details Of the Casecontrasting

confidence: 71%

Section: What Is Known and Objectivementioning

confidence: 99%

Section: Details Of the Casementioning

confidence: 99%

See 2 more Smart Citations

Reversible dilated cardiomyopathy associated with amphotericin B therapy

et al. 2014

View full text Add to dashboard Cite

show abstract

“…[85][86][87][88][89][90] Other Antifungal Medications Several cases of new-onset dilated cardiomyopathy with subsequent HF with amphotericin B and its liposomal e45 formulation have been reported. [91][92][93] In each case, HF symptoms and echocardiographic findings normalized on discontinuation of therapy, which occurred within 10 days to 6 months of drug discontinuation.…”

Section: Anti-infective Medicationsmentioning

confidence: 95%

Drugs That May Cause or Exacerbate Heart Failure

Page¹,

O’Bryant²,

Cheng³

et al. 2016

Circulation

345

185

View full text Add to dashboard Cite

Heart failure is a common, costly, and debilitating syndrome that is associated with a highly complex drug regimen, a large number of comorbidities, and a large and often disparate number of healthcare providers. All of these factors conspire to increase the risk of heart failure exacerbation by direct myocardial toxicity, drug-drug interactions, or both. This scientific statement is designed to serve as a comprehensive and accessible source of drugs that may cause or exacerbate heart failure to assist healthcare providers in improving the quality of care for these patients.

show abstract

Anthelmintics in Dermatology

Worswick¹,

Dreyer²

2018

Biologic and Systemic Agents in Dermatology

View full text Add to dashboard Cite

Reversible dilated cardiomyopathy associated with amphotericin B treatment

Cited by 16 publications

References 12 publications

Reversible dilated cardiomyopathy associated with amphotericin B therapy

Reversible dilated cardiomyopathy associated with amphotericin B therapy

Drugs That May Cause or Exacerbate Heart Failure

Anthelmintics in Dermatology

Contact Info

Product

Resources

About